Literature DB >> 12591159

Abnormal PI3 kinase/Akt signal pathway in vagal afferent neurons and vagus nerve of streptozotocin-diabetic rats.

Fang Cai1, Cinda J Helke.   

Abstract

The PI3 (phosphatidylinositol-3) kinase/Akt (protein kinase B) signal pathway is involved in the molecular signaling that regulates retrograde axonal transport of neurotrophins in the nervous system. Previous work showed that a reduced retrograde axonal transport of endogenous nerve growth factor (NGF) and neurotrophin-3 (NT-3) in the vagus nerve of diabetic rats occurred in the presence of normal production of neurotrophins and neurotrophin receptors. To assess the potential involvement of an impaired PI3 kinase/Akt signal pathway in the diabetes-induced reduction in retrograde axonal transport of neurotrophins in the vagus nerve, we characterized diabetes-induced changes in the PI3 kinase/Akt signal pathway in the vagus nerve and vagal afferent neurons. Control and streptozotocin (STZ)-induced diabetic rats with a duration of 16 weeks, kinase assays, Western blotting, and immunocytochemistry were used to show that diabetes resulted in alterations in activity and protein expression of the PI3 kinase/Akt signal pathway in the vagus nerve and vagal afferent neurons. Diabetes caused a significant decrease in enzymatic activity of PI3 kinase and Akt (52 and 36% of control, respectively) in the vagus nerve. The reduced enzymatic activity was not associated with decreased protein expression of the p85 subunit of PI3 kinase, Akt and phosphorylation of Akt (ser473). In contrast, there was a significant increase in the phosphorylation of p70s6 kinase (thr421/ser424) along with a normal protein expression of p70s6 kinase in the vagus nerve of diabetic rats. However, diabetes induced an overall decrease in immunoreactivity of the p85 subunit of PI3 kinase, phospho-Akt (ser473) and phospho-p70s6/p85s6 kinase (thr421/ser424) in vagal afferent neurons. Thus, impaired PI3 kinase/Akt signal pathway may partly account for the reduced retrograde axonal transport of neurotrophins in the vagus nerve of STZ-induced diabetic rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12591159     DOI: 10.1016/s0169-328x(02)00652-6

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  17 in total

1.  Effect of insulin and an erythropoietin-derived peptide (ARA290) on established neuritic dystrophy and neuronopathy in Akita (Ins2 Akita) diabetic mouse sympathetic ganglia.

Authors:  Robert E Schmidt; Dongyan Feng; Qiuling Wang; Karen G Green; Lisa L Snipes; Michael Yamin; Michael Brines
Journal:  Exp Neurol       Date:  2011-08-18       Impact factor: 5.330

Review 2.  Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited?

Authors:  Christopher K Rayner; Michael Horowitz
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

3.  GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway.

Authors:  Mallappa Anitha; Chetan Gondha; Roy Sutliff; Alexander Parsadanian; Simon Mwangi; Shanthi V Sitaraman; Shanthi Srinivasan
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

4.  The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.

Authors:  Ilaria Cervellini; Ezia Bello; Roberta Frapolli; Carla Porretta-Serapiglia; Norberto Oggioni; Annalisa Canta; Raffaella Lombardi; Francesca Camozzi; Ilaria Roglio; Roberto Cosimo Melcangi; Maurizio D'incalci; Giuseppe Lauria; Pietro Ghezzi; Guido Cavaletti; Roberto Bianchi
Journal:  Neurotox Res       Date:  2009-10-30       Impact factor: 3.911

5.  Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice.

Authors:  Robert E Schmidt; Karen G Green; Dongyan Feng; Denise A Dorsey; Curtis A Parvin; Jin-Moo Lee; Qinlgi Xiao; Michael Brines
Journal:  Exp Neurol       Date:  2007-10-29       Impact factor: 5.330

6.  Reduced volume-regulated outwardly rectifying anion channel activity in ventricular myocyte of type 1 diabetic mice.

Authors:  Shintaro Yamamoto; Kunihiko Ichishima; Tsuguhisa Ehara
Journal:  J Physiol Sci       Date:  2008-12-26       Impact factor: 2.781

7.  Interaction of insulin with prokinetic drugs in STZ-induced diabetic mice.

Authors:  Mohamed A Fouad Shalaby; Hekma A Abd El Latif; Mostafa E El Sayed
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-05-06

8.  Neuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons.

Authors:  Munmun Chattopadhyay; Claire Walter; Marina Mata; David J Fink
Journal:  Brain       Date:  2009-02-24       Impact factor: 13.501

Review 9.  Myopia and diabetes mellitus as modificatory factors of glaucomatous optic neuropathy.

Authors:  Etsuo Chihara
Journal:  Jpn J Ophthalmol       Date:  2013-08-15       Impact factor: 2.447

10.  Diacylglycerol kinase zeta inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus.

Authors:  Olga Bilim; Yasuchika Takeishi; Tatsuro Kitahara; Takanori Arimoto; Takeshi Niizeki; Toshiki Sasaki; Kaoru Goto; Isao Kubota
Journal:  Cardiovasc Diabetol       Date:  2008-02-04       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.